Evidence map›Paper›PMID 34026605›Full record

ArticleFrontiers in oncology2021

MRI Radiomics Signature as a Potential Biomarker for Predicting

ZhiYuan Zhang, LiJun Shen, Yan Wang, Jiazhou Wang, Hui Zhang, Fan Xia, JueFeng Wan, Zhen Zhang

Abstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

ZhiYuan ZhangDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
LiJun ShenDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Yan WangDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Jiazhou WangDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Hui ZhangDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Fan XiaDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
JueFeng WanDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhen ZhangDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeLocally advanced rectal cancer (LARC) is a heterogeneous disease with little information about MATERIAL AND

methodsEighty-three patients with

resultsThe clinical characteristics of 83 patients in the

conclusionRadiomics features could differentiate

Indexed as

KRASlocal advanced rectal cancermagnetic resonance imagingpredictionradiomic

Identifiers

PMID34026605
PMCPMC8138318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.